Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000033235 | SCV001018719 | likely benign | Congenital myasthenic syndrome 4A | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000876183 | SCV001151160 | uncertain significance | not provided | 2018-03-01 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001128140 | SCV001287548 | uncertain significance | Congenital myasthenic syndrome | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
New York Genome Center | RCV001836721 | SCV002097985 | uncertain significance | Congenital myasthenic syndrome 4A; Congenital myasthenic syndrome 4C; Congenital myasthenic syndrome 4B | 2020-06-05 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000876183 | SCV003830608 | uncertain significance | not provided | 2022-02-07 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000033235 | SCV000057091 | pathogenic | Congenital myasthenic syndrome 4A | 2018-11-07 | no assertion criteria provided | literature only | |
Natera, |
RCV001128140 | SCV001463215 | likely benign | Congenital myasthenic syndrome | 2020-05-05 | no assertion criteria provided | clinical testing |